During the last year we have learned a lot about COVID. We learned about the benefits and riosks of some anti viral therapy, ivermectin, plaquenil et al and much more. There are reports about the benefit of low dose naltrexone and even of bee venon therapy and COVID.
Recently researches at both the Hebrw Universoty and New York’sMount Sinai Hospital claims the benefit of a lipid lowering drug, fenofibrate. This drug which is NOT a statin could render COVID 19 no more dangerous than the common cold.
It has been stated that this drug borne out of clinical studies could potentially downgrade COVID 19’s severity. It has been postulated the virus prevents the routine burning of carbohydrates. As a result the large amounts of fat accumulate inside the lung cells, a condition the virus needs in order to replicate. Fenofibrate showed promising results- by allowing lung cells to burn more fat, this drug breaks the virus’s grip on these cells and prevents the COVID virus from replicating I find this unique
If it is true that the vaccine will only protect a patient for a few months- this could be one option. There are many options
Until tomorrow…